International Journal Of Tuberculosis And Lung Disease
(INT J TUBERC LUNG D) 《国际肺结核与肺病杂志》

 Empirical use of fluoroquinolones for chest infections may mask tuberculosis and jeopardise chances of survival [Editorial] 
pp. 1137-1137(1) 
Authors: Leung, Chi Chiu; Caminero, Jose A.

 Finding tuberculosis at the first encounter with HIV care: don't miss the opportunity to save a life[Editorial] 
pp. 1138-1138(1) 
Authors: Cain, Kevin P.; Varma, Jay K.

 New solutions in service design and delivery are necessary to combat disease burden [Editorial] 
pp. 1139-1139(1) 
Author: George, Gerard

 Enabling biomarkers for tuberculosis control [State of the Art Series. New tools. Number 3 in the series] 
pp. 1140-1148(9) 
Authors: Maertzdorf, J.; Weiner III, J.; Kaufmann, S. H. E.

Adverse respiratory effects of outdoor air pollution in the elderly [Review article] 
pp. 1149-1161(13) 
Authors: Bentayeb, M.; Simoni, M.; Baiz, N.; Norback, D.; Baldacci, S.; Maio, S.; Viegi, G.; Annesi-Maesano, I.; Geriatric Study in Europe on Health Effects of Air Quality in Nursing Homes GERIE Group,

Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death 
pp. 1162-1167(6) 
Authors: van der Heijden, Y. F.; Maruri, F.; Blackman, A.; Holt, E.; Warkentin, J. V.; Shepherd, B. E.; Sterling, T. R.

Tuberculosis screening in prescribers of anti-tumor necrosis factor therapy in the European Union 
pp. 1168-1173(6) 
Authors: Smith, M. Y.; Attig, B.; McNamee, L.; Eagle, T.

Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis 
pp. 1174-1179(6) 
Authors: Van Deun, A.; Maug, A. K. J.; Hossain, A.; Gumusboga, M.; de Jong, B. C.

¹⁸F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response 
pp. 1180-1185(6) 
Authors: Martinez, V.; Castilla-Lievre, M. A.; Guillet-Caruba, C.; Grenier, G.; Fior, R.; Desarnaud, S.; Doucet-Populaire, F.; Boué, F.

Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins 
pp. 1186-1189(4) 
Author: Mitchison, D. A.

Comparison of specificities between two interferon-gamma release assays in Japan [Short communication] 
pp. 1190-1192(3) 
Authors: Higuchi, K.; Sekiya, Y.; Igari, H.; Watanabe, A.; Harada, N.

Delays in the diagnosis of pulmonary tuberculosis in Coahuila, Mexico 
pp. 1193-1198(6) 
Authors: Salinas, J.; Calvillo, S.; Caylà, J.; Nedel, F. B.; Martín, M.; Navarro, A.

Mortality among tuberculosis patients in the Democratic Republic of Congo 
pp. 1199-1204(6) 
Authors: Henegar, C.; Behets, F.; Vanden Driessche, K.; Tabala, M.; Bahati, E.; Bola, V.; Van Rie, A.

Comparative study of the profiles of tribal and non-tribal tuberculosis patients in a tuberculosis unit of West Bengal, India 
pp. 1205-1209(5) 
Authors: Chakrabarti, S.; Saha, I.; Das, D. K.; Prasad Sarkar, A.; Roy, R.; Hossain, A.

Manifestations of tuberculosis in elderly versus young hospitalised patients in Amritsar, India 
pp. 1210-1213(4) 
Authors: Bhushan, B.; Kajal, N. C.; Maske, A.; Singh, S. P.

Qualitative study of perceived causes of tuberculosis treatment default among health care workers in Morocco 
pp. 1214-1220(7) 
Authors: Kizub, D.; Ghali, I.; Sabouni, R.; Bourkadi, J. E.; Bennani, K.; El Aouad, R.; Dooley, K. E.

Factors leading to under-reporting of tuberculosis in the private sector in Korea 
pp. 1221-1227(7) 
Authors: Hong, S-J.; Park, Y-S.; An, H.; Kang, S-M.; Cho, E-H.; Shin, S-S.

Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis 
pp. 1228-1233(6) 
Authors: Blöndal, K.; Viiklepp, P.; Guðmundsson, L. J.; Altraja, A.

Epidemiology of smear-negative pulmonary tuberculosis in the United States, 1993-2008 
pp. 1234-1240(7) 
Authors: Shah, N. S.; Cavanaugh, J. S.; Pratt, R.; Cain, K. P.; Wells, C.; Laserson, K.; Nelson, L.

Experiences in implementation of routine human immunodeficiency virus testing in a US tuberculosis clinic 
pp. 1241-1246(6) 
Authors: Gardner, A.; Naureckas, C.; Beckwith, C.; Losikoff, P.; Martin, C.; Carter, E. J.

A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein 
pp. 1247-1251(5) 
Authors: Alvarez, G. G.; Sabri, E.; Ling, D.; Cameron, D. W.; Maartens, G.; Wilson, D.

Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding 
pp. 1252-1259(8) 
Authors: Hanifa, Y.; Fielding, K. L.; Charalambous, S.; Variava, E.; Luke, B.; Churchyard, G. J.; Grant, A. D.

Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients 
pp. 1260-1264(5) 
Authors: Lehloenya, R. J.; Wallace, J.; Todd, G.; Dheda, K.

Drug lymphocyte stimulation test is not useful for side effects of anti-tuberculosis drugs despite its timing 
pp. 1265-1269(5) 
Authors: Miwa, S.; Suzuki, Y.; Shirai, M.; Ohba, H.; Kanai, M.; Eifuku, T.; Suda, T.; Hayakawa, H.; Chida, K.

Indian Study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis in adults (INSEARCH) 
pp. 1270-1277(8) 
Authors: Jindal, S. K.; Aggarwal, A. N.; Gupta, D.; Agarwal, R.; Kumar, R.; Kaur, T.; Chaudhry, K.; Shah, B.

Drug-induced hypothyroidism in patients receiving treatment for multidrug-resistant tuberculosis in the UK [Correspondence] 
pp. 1278-1278(1) 
Authors: Gupta, J.; Breen, R. A. M.; Milburn, H. J.